PPT-Implementing Addiction Treatment Trials in Medical Settings

National Drug Abuse Treatment Clinical Trials Network AA Forcehimes 1 MP Bogenschutz 1 DM Donovan 2 C Crandall 1 R Lindblad 3 R Mandler 4 HI Perl 4 R Walker. David Kan, M.D.. University of California. San Francisco. VA Medical Center. San Francisco. History of Opioids. The “Pod of Pleasure”. OTC Opiates. Opium. Smoker. Opium in San Francisco. Gentlemen prefer…opium. Richard A. Rawson, Ph.D, Professor. Semel. Institute for Neuroscience and Human Behavior. David Geffen School of Medicine. University of California at Los Angeles. www.uclaisap.org. rrawson@mednet.ucla.edu. Protocol=study plan which details what researchers will do in the study. It describes what types of people may participate in the trial; the schedule of tests, procedures, medications, and dosages; and the length of the study. . . 83. rd. Ohio House District. 6. 7. What has caused our current addiction epidemic?. Pain as the Fifth . V. ital . S. ign. Intractable Pain Act. Introduction of new pain medications. Marketing strategies. Richard A. Rawson, Ph.D, Professor. Semel. Institute for Neuroscience and Human Behavior. David Geffen School of Medicine. University of California at Los Angeles. www.uclaisap.org. rrawson@mednet.ucla.edu. MAT BASICS Peter Mason MD Medical Director Region 1 IDN Opioid Use Disorder (OUD) Opioid Use Disorder (OUD): A medical condition characterized by a problematic pattern of opioid use that causes clinically significant impairment or distress. Jamie Marich, Ph.D., LPCC-S, LICDC-CS. Director, Mindful Ohio. About Today’s Presenter. Licensed Supervising Professional Clinical Counselor (MH). Licensed Independent Chemical Dependency Counselor. Substance Use Disorders 101 for Primary Care . Providers. Ariel Singer, MPH – Northwest Addiction Technology Transfer Center/OHSU. Anderson Rice, LPC, CADC I – Kaiser Permanente Addiction Medicine. Thomas M. Workman, PhD, LPC, NCC, ACS. Kevin Caridad, PhD, LCSW. Objectives. To identify the primary historical shifts in the conceptualization of addiction. Develop a basic understanding of the genetic and neuropsychological factors influencing addiction. April 2022. Daniel P. Alford, MD, MPH. Professor of Medicine. Associate Dean, Continuing Medical Education. Director, Clinical Addiction Research and Education (CARE) Unit. 32-year-old male brought into the Emergency Department after and “opioid overdose”.  . A Congressional Briefing Sponsored . by. The Addiction Medicine . Foundation. In cooperation . with. The Congressional Prescription Drug Abuse Caucus. The Congressional Addiction, Treatment and Recovery Caucus . April 2023. Daniel P. Alford, MD, MPH. Professor of Medicine. Associate Dean, Continuing Medical Education. Director, Clinical Addiction Research and Education (CARE) Unit. 32-year-old male brought into the Emergency Department after an “opioid overdose”. Community Justice & Safety Symposium. March 3, 2020. Mae Katt, Nurse Practitioner. Outline. Topic: Opioid Addiction. Mae Katt, NP. Dr Claudette Chase. Edna . Quequish. Swanson . Kenequanash. . Questions & Discussion. Knox County . CON Application No. CN2401-002. Cedar Recovery of Middle Tennessee, LLC. Local company founded in 2015 and headquartered in Mt. Juliet.. Owns and operates 13 outpatient addiction treatment clinics in Tennessee and Virginia (“OBOTs” for Office Based Opioid Treatment), including 2 in Knoxville..